Category: Peptide Q&A
-
How do double-blind, placebo-controlled trials on Selank compare to open-label or animal studies in terms of methodological rigor?
How do double-blind, placebo-controlled trials on Selank compare to open-label or animal studies in terms of methodological rigor?
-
What cognitive and emotional benefits are reported in human trials involving Selank administration for anxiety and stress-related disorders?
What cognitive and emotional benefits are reported in human trials involving Selank administration for anxiety and stress-related disorders?
-
What meta-analyses or systematic reviews have evaluated the overall effect size of Selank on anxiety and cognitive performance?
What meta-analyses or systematic reviews have evaluated the overall effect size of Selank on anxiety and cognitive performance?
-
What are the limitations of current animal studies on NAD+ and how do they affect the translation of findings to human applications?
What are the limitations of current animal studies on NAD+ and how do they affect the translation of findings to human applications?
-
How do the effects of NAD+ precursors on cognitive performance compare to those of other nootropics like phosphatidylserine or bacopa monnieri?
How do the effects of NAD+ precursors on cognitive performance compare to those of other nootropics like phosphatidylserine or bacopa monnieri?
-
How does combining NAD+ precursors with other longevity-promoting compounds (e.g., resveratrol, metformin) affect efficacy and safety profiles?
How does combining NAD+ precursors with other longevity-promoting compounds (e.g., resveratrol, metformin) affect efficacy and safety profiles?
-
How does NAD+ regulate autophagy through SIRT1 and mTOR signaling, and what role does this play in preventing protein aggregation in neurodegenerative diseases?
How does NAD+ regulate autophagy through SIRT1 and mTOR signaling, and what role does this play in preventing protein aggregation in neurodegenerative d